March 01, 2019
2 min read
Save

Top cardiology news from February: Salt substitutes, sweetened beverages and more

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Cardiology Today compiled a list of the most-read stories posted to Healio.com/Cardiology in February. This month, our readers were interested in how a low-sodium salt diet may lower BP, several studies on physical activity or the lack thereof, key FDA recalls and much more.

First patient treated in IDE trial of novel AF ablation catheter

Biosense Webster, a Johnson & Johnson company, announced that the first patient has been enrolled and treated in an investigational device exemption study of a novel catheter for ablation of patients with atrial fibrillation.

Read More

FDA designates recall of several implanted cardiac pacemakers as class 1

The FDA has designated Medtronic’s product recall of implanted cardiac pacemakers as a class 1 recall, the most serious kind. The recall affects 13,440 devices manufactured and distributed between March 2, 2017, and Jan. 7, 2019.

Read More

Low-sodium salt substitute diet may lower systolic, diastolic BP

Implementing low-sodium salt substitutes in a diet can lead to a significant lowering of systolic and diastolic BP, according to a meta-analysis published in Heart.

Read More

Artificially sweetened beverages increase risk for stroke in women

Patients who had a high intake of artificially sweetened beverages had increased risks for stroke, CHD, small artery occlusion ischemic stroke and all-cause mortality, according to a study published in Stroke.

Read More

ANNEXA-4: Andexanet alfa successfully reverses factor Xa inhibitor effects

Andexanet alfa reversed the anticoagulation effects of factor Xa inhibitors in most patients with acute major bleeding caused by a factor Xa inhibitor, according to the full data from the ANNEXA-4 study presented at the International Stroke Conference.

Read More

Anti-inflammatory psoriasis agents could reduce coronary artery plaque

Anti-inflammatory biologic therapy for treatment of severe psoriasis reduced coronary artery plaque, raising questions about whether such agents could have a role in prevention of CHD, researchers reported in Cardiovascular Research.

Read More

Higher push-up capacity decreases risk for CVD events

Patients with higher push-up capacity had a decreased risk for CVD events, according to a study published in JAMA Network Open.

Read More

Sedentary lifestyle increases risk for CVD in older women

Older women who were sedentary for long periods of time throughout the day had an increased risk for CVD, according to a study published in Circulation.

Read More

PAGE BREAK

Acute MI hospitalizations increased in young patients

The number of young adults who were hospitalized for acute MI increased from 1995 to 2014, and this trend was more distinct in young women, according to a study published in Circulation.

Read More

FDA alerts health care providers of mortality concern with right heart pump system

The FDA has issued a letter to health care providers regarding the increased rate of mortality in patients who have received a temporary right heart pump system in a recent interim postapproval study compared with what was previously observed in premarket clinical studies.

Read More